why is semaglutide being discontinued Compounded GLP-1 - & Tirzepatide Study Shows 58% Of Patients

Immune and inflammatory mechanisms in hypertension

The NHS position emphasises that individuals with metabolic conditions should follow evidence-based treatment plans developed with healthcare professionals

Continuous GLP-1RA Use Reduces MACE Risk Incident use of GLP-1RAs was associated with a lower risk of MACE compared to incident use of sulfonylureas

Buttar PA, Mazhar MU, Khan JZ, Jamil M, Abid M, Tipu MK (2025) Saccharomyces boulardii (CNCM I-745) ameliorates ovalbumin-induced atopic dermatitis by modulating the NF-B signaling in skin and colon

Some patients respond dramatically better to tirzepatide after semaglutide plateaus